Crystalys Therapeutics Funding: $205M Raised, Series A
Crystalys Therapeutics is a Biotech company based in San Diego. It has raised $205M in total funding. Latest round: Series A.
Crystalys Therapeutics funding overview
Crystalys Therapeutics is a Biotech company based in San Diego. Crystalys Therapeutics has raised $205M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Crystalys Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Novo Holdings, SR One, Catalys Pacific, Perceptive Xontogeny Venture Funds, Lightstone Ventures, AN Venture Partners and 7 others. 13 distinct backers are named across the disclosed rounds.
Crystalys Therapeutics at a glance
Total raised
$205M
Latest round
Series A
Latest round date
September 2025
Industry
Biotech
Headquarters
San Diego
Notable investors
Novo Holdings, SR One, Catalys Pacific, Perceptive Xontogeny Venture Funds, Lightstone Ventures, AN Venture Partners, abrdn Inc., KB Investments
Frequently asked about Crystalys Therapeutics funding
How much has Crystalys Therapeutics raised?
Crystalys Therapeutics has raised $205M in total disclosed funding across the rounds on record.
Who has invested in Crystalys Therapeutics?
Novo Holdings, SR One, Catalys Pacific, Perceptive Xontogeny Venture Funds, Lightstone Ventures, AN Venture Partners are named among the investors backing Crystalys Therapeutics.
What was the latest Crystalys Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Crystalys Therapeutics based?
Crystalys Therapeutics is based in San Diego.
What sector does Crystalys Therapeutics operate in?
Crystalys Therapeutics is tracked under Biotech from San Diego, with $205M in disclosed funding.
When did Crystalys Therapeutics last raise?
The last disclosed Crystalys Therapeutics round closed in September 2025 at Series A.
Round data for Crystalys Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Diego and backer lists below.
